“…TRPV4 is a polymodal Ca 2+ permeable non-selective ion channel (Liedtke, 2007), mutations in which leads to a phenotypically diverse range of severe skeletal conditions including lethal metatropic dysplasia, spondylometaphyseal dysoplasia (dwarfirm), and autosomal dominant brachyolmia (Camacho et al, 2010; Nilius & Voets, 2013; Nishimura et al, 2012). First discovered in 2000 (Liedtke et al, 2000; Strotmann et al, 2000), TRPV4 was initially found to be responsible for transducing osmotic signals (Liedtke & Friedman, 2003), but has since been implicated in the cell biosynthetic response to compressive loading (O’Conor et al, 2014), hydrostatic pressure (Savadipour et al, 2022) and oscillatory fluid shear (Corrigan et al, 2018). Previous work has found a critical role for TRPV4 in cartilage and bone cell function in vitro .…”